Article Versions Notes

Spartalis M, Kasimatis E, Liakou E, Sampani E, Lioulios G, Christodoulou M, Stai S, Moysidou E, Efstratiadis G, Papagianni A. Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis. Life. 2023; 13(2):454. https://doi.org/10.3390/life13020454

Spartalis, Michalis, Efstratios Kasimatis, Eleni Liakou, Erasmia Sampani, Georgios Lioulios, Michalis Christodoulou, Stamatia Stai, Eleni Moysidou, George Efstratiadis, and Aikaterini Papagianni. 2023. "Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis" Life 13, no. 2: 454. https://doi.org/10.3390/life13020454

Spartalis, M., Kasimatis, E., Liakou, E., Sampani, E., Lioulios, G., Christodoulou, M., Stai, S., Moysidou, E., Efstratiadis, G., & Papagianni, A. (2023). Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis. Life, 13(2), 454. https://doi.org/10.3390/life13020454